240 related articles for article (PubMed ID: 10837486)
1. BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival.
Tan Y; Demeter MR; Ruan H; Comb MJ
J Biol Chem; 2000 Aug; 275(33):25865-9. PubMed ID: 10837486
[TBL] [Abstract][Full Text] [Related]
2. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation.
Datta SR; Katsov A; Hu L; Petros A; Fesik SW; Yaffe MB; Greenberg ME
Mol Cell; 2000 Jul; 6(1):41-51. PubMed ID: 10949026
[TBL] [Abstract][Full Text] [Related]
3. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155.
Zhou XM; Liu Y; Payne G; Lutz RJ; Chittenden T
J Biol Chem; 2000 Aug; 275(32):25046-51. PubMed ID: 10837473
[TBL] [Abstract][Full Text] [Related]
4. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155.
Lizcano JM; Morrice N; Cohen P
Biochem J; 2000 Jul; 349(Pt 2):547-57. PubMed ID: 10880354
[TBL] [Abstract][Full Text] [Related]
5. Survival-factor-induced phosphorylation of Bad results in its dissociation from Bcl-x(L) but not Bcl-2.
Hirai I; Wang HG
Biochem J; 2001 Oct; 359(Pt 2):345-52. PubMed ID: 11583580
[TBL] [Abstract][Full Text] [Related]
6. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity.
Zha J; Harada H; Osipov K; Jockel J; Waksman G; Korsmeyer SJ
J Biol Chem; 1997 Sep; 272(39):24101-4. PubMed ID: 9305851
[TBL] [Abstract][Full Text] [Related]
7. p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association.
Jin S; Zhuo Y; Guo W; Field J
J Biol Chem; 2005 Jul; 280(26):24698-705. PubMed ID: 15849194
[TBL] [Abstract][Full Text] [Related]
8. Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway.
Fang X; Yu S; Eder A; Mao M; Bast RC; Boyd D; Mills GB
Oncogene; 1999 Nov; 18(48):6635-40. PubMed ID: 10597268
[TBL] [Abstract][Full Text] [Related]
9. Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL.
Kelekar A; Chang BS; Harlan JE; Fesik SW; Thompson CB
Mol Cell Biol; 1997 Dec; 17(12):7040-6. PubMed ID: 9372935
[TBL] [Abstract][Full Text] [Related]
10. p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis.
Schürmann A; Mooney AF; Sanders LC; Sells MA; Wang HG; Reed JC; Bokoch GM
Mol Cell Biol; 2000 Jan; 20(2):453-61. PubMed ID: 10611223
[TBL] [Abstract][Full Text] [Related]
11. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD.
Wang HG; Pathan N; Ethell IM; Krajewski S; Yamaguchi Y; Shibasaki F; McKeon F; Bobo T; Franke TF; Reed JC
Science; 1999 Apr; 284(5412):339-43. PubMed ID: 10195903
[TBL] [Abstract][Full Text] [Related]
12. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L).
Zha J; Harada H; Yang E; Jockel J; Korsmeyer SJ
Cell; 1996 Nov; 87(4):619-28. PubMed ID: 8929531
[TBL] [Abstract][Full Text] [Related]
13. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins.
Ottilie S; Diaz JL; Horne W; Chang J; Wang Y; Wilson G; Chang S; Weeks S; Fritz LC; Oltersdorf T
J Biol Chem; 1997 Dec; 272(49):30866-72. PubMed ID: 9388232
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3beta is a p90 ribosomal S6 kinase (RSK) isoform 1-binding protein that negatively regulates RSK kinase activity.
Cavet ME; Lehoux S; Berk BC
J Biol Chem; 2003 May; 278(20):18376-83. PubMed ID: 12618428
[TBL] [Abstract][Full Text] [Related]
15. The FLT3 internal tandem duplication mutation prevents apoptosis in interleukin-3-deprived BaF3 cells due to protein kinase A and ribosomal S6 kinase 1-mediated BAD phosphorylation at serine 112.
Yang X; Liu L; Sternberg D; Tang L; Galinsky I; DeAngelo D; Stone R
Cancer Res; 2005 Aug; 65(16):7338-47. PubMed ID: 16103085
[TBL] [Abstract][Full Text] [Related]
16. Altered Bad localization and interaction between Bad and Bcl-xL in the hippocampus after transient global ischemia.
Abe T; Takagi N; Nakano M; Furuya M; Takeo S
Brain Res; 2004 May; 1009(1-2):159-68. PubMed ID: 15120593
[TBL] [Abstract][Full Text] [Related]
17. The chaperone protein 14-3-3 interacts with 3BP2/SH3BP2 and regulates its adapter function.
Foucault I; Liu YC; Bernard A; Deckert M
J Biol Chem; 2003 Feb; 278(9):7146-53. PubMed ID: 12501243
[TBL] [Abstract][Full Text] [Related]
18. ArgBP2gamma interacts with Akt and p21-activated kinase-1 and promotes cell survival.
Yuan ZQ; Kim D; Kaneko S; Sussman M; Bokoch GM; Kruh GD; Nicosia SV; Testa JR; Cheng JQ
J Biol Chem; 2005 Jun; 280(22):21483-90. PubMed ID: 15784622
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel phosphorylation site, Ser-170, as a regulator of bad pro-apoptotic activity.
Dramsi S; Scheid MP; Maiti A; Hojabrpour P; Chen X; Schubert K; Goodlett DR; Aebersold R; Duronio V
J Biol Chem; 2002 Feb; 277(8):6399-405. PubMed ID: 11717309
[TBL] [Abstract][Full Text] [Related]
20. Activation of JNK1, RSK2, and MSK1 is involved in serine 112 phosphorylation of Bad by ultraviolet B radiation.
She QB; Ma WY; Zhong S; Dong Z
J Biol Chem; 2002 Jul; 277(27):24039-48. PubMed ID: 11983683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
